Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate versus placebo in amyotrophic lateral sclerosis
NL-OMON21077Active, not recruiting
- Sponsor
- Prof.dr L.H. van den Berg, neurologist in the University Hospital of Utrecht
- Start
- Oct 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in amyotrophic lateral sclerosis (ALS) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: Survival. Started Oct 2008; status: active, not recruiting.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NL-OMON21077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21077.